Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Effect of growth hormone therapy on serum adiponectin and resistin levels in short, small-for-gestational-age children and associations with cardiovascular risk parameters.

Willemsen RH, van Dijk M, de Rijke YB, van Toorenenbergen AW, Mulder PG, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2007 Jan;92(1):117-23. Epub 2006 Sep 26.

PMID:
17003095
2.

Long-term GH treatment is not associated with disadvantageous changes of inflammatory markers and adipocytokines in children born small for gestational age.

Willemsen RH, Mulder PG, van Toorenenbergen AW, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Feb;68(2):198-205. Epub 2007 Aug 29.

PMID:
17760882
3.

Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.

Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.

Horm Res. 2003;60 Suppl 3:113-4.

PMID:
14671407
4.

Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.

Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LM, Carlsson B, Albertsson-Wikland K.

Eur J Endocrinol. 1997 Oct;137(4):387-95.

5.

Children born small-for-gestational age: postnatal growth and hormonal status.

Albertsson-Wikland K, Boguszewski M, Karlberg J.

Horm Res. 1998;49 Suppl 2:7-13.

PMID:
9730665
6.

Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin.

Ibáñez L, Lopez-Bermejo A, Díaz M, Jaramillo A, Marín S, de Zegher F.

J Clin Endocrinol Metab. 2010 May;95(5):2234-9. doi: 10.1210/jc.2009-2805. Epub 2010 Mar 23.

PMID:
20332245
7.

Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.

van Dijk M, Bannink EM, van Pareren YK, Mulder PG, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2007 Jan;92(1):160-5. Epub 2006 Oct 24.

PMID:
17062774
8.

IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.

Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.

Horm Res. 2005;64(2):68-76. Epub 2005 Aug 19.

PMID:
16113581
9.

Serum dehydroepiandrosterone sulfate levels and pubarche in short children born small for gestational age before and during growth hormone treatment.

Boonstra VH, Mulder PG, de Jong FH, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2004 Feb;89(2):712-7.

PMID:
14764786
10.

Low serum adiponectin levels are associated with reduced insulin sensitivity and lipid disturbances in short children born small for gestational age.

Huang Y, Li Y, Chen Q, Chen H, Ma H, Su Z, Du M.

Clin Endocrinol (Oxf). 2015 Jul;83(1):78-84. doi: 10.1111/cen.12663. Epub 2014 Dec 11.

PMID:
25382353
11.

Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA).

Arends NJ, Boonstra VH, Duivenvoorden HJ, Hofman PL, Cutfield WS, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2005 Jan;62(1):44-50.

PMID:
15638869
12.

Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.

Renes JS, de Ridder MA, Breukhoven PE, Lem AJ, Hokken-Koelega AC.

PLoS One. 2012;7(12):e53164. doi: 10.1371/journal.pone.0053164. Epub 2012 Dec 27.

13.

Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.

Hokken-Koelega AC, De Waal WJ, Sas TC, Van Pareren Y, Arends NJ.

J Pediatr Endocrinol Metab. 2004 Mar;17 Suppl 3:463-9.

PMID:
15134308
14.
15.

Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.

Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2007 Aug;92(8):2992-3000. Epub 2007 May 15.

PMID:
17504895
16.

Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age.

Ibáñez L, López-Bermejo A, Díaz M, Marcos MV, Casano P, de Zegher F.

J Clin Endocrinol Metab. 2009 Mar;94(3):1049-52. doi: 10.1210/jc.2008-2176. Epub 2008 Dec 9.

PMID:
19066297
17.

Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.

de Kort SW, Willemsen RH, van der Kaay DC, van Dijk M, Visser TJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Aug;69(2):318-22. doi: 10.1111/j.1365-2265.2008.03195.x. Epub 2008 Jan 23.

PMID:
18221400
18.

Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.

Boguszewski M, Bjarnason R, Rosberg S, Carlsson LM, Albertsson-Wikland K.

J Clin Endocrinol Metab. 1997 Apr;82(4):1014-9.

PMID:
9100566
19.

Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis.

Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP, Saenger P.

Horm Res. 2006;65 Suppl 3:153-9. Epub 2006 Apr 10.

PMID:
16612129
20.

Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age.

Kamoda T, Nozue H, Matsui A.

Clin Endocrinol (Oxf). 2007 Feb;66(2):290-4.

PMID:
17224001
Items per page

Supplemental Content

Write to the Help Desk